Marginalization and factors associated with early mortality among patients diagnosed with de novo metastatic breast cancer in Ontario, Canada

被引：0
|
作者：
Thomas, P. [1 ]
Carter, B. [2 ]
Earle, C. [3 ]
Sharriff, S. [2 ]
Raphael, J. [4 ]
Mahar, A. [5 ]
Knowles, S. [6 ]
Brackstone, M. [6 ]
Lock, M. [7 ]
Eisen, A. [3 ]
Blanchette, P. [4 ]
机构：
[1] Univ Western Ontario, Dept Med, London, ON, Canada
[2] ICES, Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Med Oncol, Toronto, ON, Canada
[4] London Reg Canc Program LRCP London Hlth Sci Ctr, Div Med Oncol, London, ON, Canada
[5] Queens Canc Res Inst QCRI, Div Canc Care & Epidemiol, Kingston, ON, Canada
[6] London Hlth Sci Ctr, Div Gen Surg, London, ON, Canada
[7] London Hlth Sci Ctr, Div Radiat Oncol, London, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.371
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
423P
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [1] Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study
    Vaz-Luis, Ines
    Lin, Nancy U.
    Keating, Nancy L.
    Barry, William T.
    Winer, Eric P.
    Freedman, Rachel A.
    ONCOLOGIST, 2017, 22 (04): : 386 - 393
  • [2] Clinicopathologic factors associated with de novo metastatic breast cancer
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (12) : 1167 - 1173
  • [3] Breast Cancer Mortality Hot Spots Among Black Women With de Novo Metastatic Breast Cancer
    Han, Yunan
    Langston, Marvin
    Fuzzell, Lindsay
    Khan, Saira
    Lewis-Thames, Marquita W.
    Colditz, Graham A.
    Moore, Justin Xavier
    JNCI CANCER SPECTRUM, 2021, 5 (01)
  • [4] Prognostic Factors and Their Impact on Survival in Patients with De Novo Metastatic Breast Cancer
    Erdis, Eda
    Yilmaz, Mukaddes
    Ucar, Mahmut
    Yucel, Birsen
    Karadayi, Kursat
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2025, 35 (01): : 41 - 50
  • [5] Factors Associated with Time to Progression and Overall Survival in Patients with De Novo Metastatic Breast Cancer: A Colombian Cohort
    Esperanza Diaz-Casas, Sandra
    Briceno-Morales, Ximena
    Juliana Puerto-Horta, Leidy
    Lehmann-Mosquera, Carlos
    Cecilia Orozco-Ospino, Martha
    Hernan Guzman-AbiSaab, Luis
    Angel-Aristizabal, Javier
    Garcia-Mora, Mauricio
    Alfonso Duarte-Torres, Carlos
    Fernando Marino-Lozano, Ivan
    Briceno-Morales, Clara
    Sanchez-Pedraza, Ricardo
    ONCOLOGIST, 2022, 27 (02): : E142 - E150
  • [6] Demographic, clinical, and histopathological factors associated with increased risk of de novo metastatic disease in patients with breast cancer
    Cuadrado-Franco, Daniela Maria
    Lehmann-Mosquera, Carlos
    Marino-Lozano, Ivan
    Nunez-Lemus, Marcela
    Sanchez-Pedraza, Ricardo
    Silva-Cardenas, Sonia
    Garcia-Mora, Mauricio
    Angel-Aristizabal, Javier
    Abi-Saab, Luis Guzman
    Suarez-Rodriguez, Raul
    Briceno-Morales, Ximena
    Martinez-Villacres, Juanita
    Diaz-Casas, Sandra
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 (04): : 443 - 454
  • [7] Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer
    Bitencourt, Almir
    Rossi Saccarelli, Carolina
    Morris, Elizabeth A.
    Flynn, Jessica
    Zhang, Zhigang
    Khan, Atif
    Gillespie, Erin
    Cahlon, Oren
    Mueller, Boris
    Cuaron, John J.
    McCormick, Beryl
    Powell, Simon N.
    Plitas, George
    Razavi, Pedram
    Pinker, Katja
    Riedl, Christopher C.
    Sutton, Elizabeth J.
    Braunstein, Lior Z.
    JAMA NETWORK OPEN, 2020, 3 (10)
  • [8] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    D J A Lobbezoo
    R J W van Kampen
    A C Voogd
    M W Dercksen
    F van den Berkmortel
    T J Smilde
    A J van de Wouw
    F P J Peters
    J M G H van Riel
    N A J B Peters
    M de Boer
    P G M Peer
    V C G Tjan-Heijnen
    British Journal of Cancer, 2015, 112 : 1445 - 1451
  • [9] Prognosis of metastatic breast cancer: Differences between patients with de novo and recurrent metastatic breast cancer
    Tjan-Heijnen, V. C. G.
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Dercksen, M. W.
    Voogd, A. C.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    van Riels, J. M. G. H.
    Peters, N. A. J. B.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S72 - S73
  • [10] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Voogd, A. C.
    Dercksen, M. W.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    Peters, F. P. J.
    van Riel, J. M. G. H.
    Peters, N. A. J. B.
    de Boer, M.
    Peer, P. G. M.
    Tjan-Heijnen, V. C. G.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1445 - 1451
12345